Chelsea Clinton
Adjunct Assistant Professor @ Columbia University's Mailman School of Public Health
New York, United States
Chelsea Clinton is a seed investor at Columbia University's Mailman School of Public Health in New York focused on Health Care and Medical. Chelsea Clinton is based out of New York, New York, and was the Board of Director of Clover Health. Chelsea Clinton attended the University of Oxford.
- Total investments:
- 23
- Last investment:
- Lead investor:
- 9%
Last updated:
For AI agents: llms.txt
Industries Chelsea Clinton invests in
Stages Chelsea Clinton invests in
Countries Chelsea Clinton invests in
Round sizes
Round size
- Seed
- $2M–$8.8M
- Series A
- $10M–$130M
Investment Focus
Industry
- Health Care 9 (39%)
- Medical 4 (17%)
- Health Diagnostics 3 (13%)
- Apps 2 (9%)
- Women's 2 (9%)
Stage
- Seed 9 (39%)
- Series A 6 (26%)
- Funding Round 3 (13%)
- Pre-Seed 2 (9%)
- Series B 2 (9%)
Country
- United States 14 (61%)
- Canada 1 (4%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Opus
|
Opus is a hospitality training platform purpose-built for the frontline that provides digital tools to help service staff learn skills, complete training modules, and access performance resources. The platform offers structured learning pathways, micro-lessons, and interactive content tailored to operational roles such as servers, housekeepers,bartenders, and guest services teams. It supports onboarding, upskilling, and continuous education by enabling employees to engage with training materials on mobile devices and track progress through competency checklists. Opus also includes features for managers to assign courses, monitor completion rates, and align training activities with service standards and operational needs. The platform integrates assessment and feedback mechanisms that help learners reinforce knowledge and demonstrate proficiency in core hospitality tasks. Through its digital training infrastructure, Opus supports workforce development and skill alignment within hospitality environments. | $9M / Series B / Feb 24, 2026 | |
Blooming Health
|
Blooming Health uses technology to help seniors with social connectedness. The company provides a solution for addressing social isolation and loneliness in older adults by delivering cell-phone-based, automated text messaging and voice calling services to enable broad access to older adults. | $26M / Series A / Apr 29, 2025 | |
Teal Health
|
Teal Health is on a mission to empower women when it comes to their health – starting with at-home cervical cancer screenings. We believe that it’s time for women’s health to be designed for women, their preferences, and their experiences. With this in mind, Teal Health is creating the first FDA-approved at-home cervical cancer screening makingit simple for a woman to stay current on this life-saving screening from the comfort, convenience, and privacy of her home. Through timely screenings, Teal health plans to eradicate cervical cancer in the US.Teal is backed by passionate and committed investors who share this important vision, including Felicis Ventures, Emerson Collective, Metrodora, and Serena Ventures. | $10M / Seed / Jan 16, 2025 | |
Summer Health
|
Summer Health is the first step and ongoing tool for anyone navigating health concerns, offering timely text access to high-quality healthcare professionals who provide expert answers and reliable advice over text. | $11.7M / Series A / Apr 23, 2024 | |
Ounce of Care
|
Ounce provides care coordination and wraparound services to residents of affordable housing to improve community health & wellbeing. | $5.2M / Seed / Oct 04, 2023 | |
|
Blooming Health
|
Blooming Health uses technology to help seniors with social connectedness. The company provides a solution for addressing social isolation and loneliness in older adults by delivering cell-phone-based, automated text messaging and voice calling services to enable broad access to older adults. | $4.2M / Seed / Sep 06, 2023 | |
|
Teal Health
|
Teal Health is on a mission to empower women when it comes to their health – starting with at-home cervical cancer screenings. We believe that it’s time for women’s health to be designed for women, their preferences, and their experiences. With this in mind, Teal Health is creating the first FDA-approved at-home cervical cancer screening makingit simple for a woman to stay current on this life-saving screening from the comfort, convenience, and privacy of her home. Through timely screenings, Teal health plans to eradicate cervical cancer in the US.Teal is backed by passionate and committed investors who share this important vision, including Felicis Ventures, Emerson Collective, Metrodora, and Serena Ventures. | $8.8M / Seed / Jan 31, 2023 | |
Oula Health
|
Oula is redesigning maternity care from the ground up. Its modern maternity center combines the best of obstetrics and midwifery care to deliver a more evidence-based and personalized pregnancy experience. From its collaborative medical team, welcoming clinic, and remote care platform, we are setting a new standard for pregnancy that unifies modernmedicine and human intuition.The company was founded in 2019 and is headquartered in Brooklyn, New York. | $19.1M / Series A / Jan 12, 2023 | |
|
Summer Health
|
Summer Health is the first step and ongoing tool for anyone navigating health concerns, offering timely text access to high-quality healthcare professionals who provide expert answers and reliable advice over text. | $7.5M / Seed / Jul 25, 2022 | |
Swing Therapeutics
|
Swing is creating the next generation of safe and effective digital therapeutics for people with chronic conditions. Our team of passionate scientists, clinicians, and technologists are partnering with some of the world’s top researchers to develop evidence-based transformative digital treatments. Swing’s solutions empower patients to regaincontrol of their illnesses. Together, we are helping people achieve improved health so that they can lead more joyful, vibrant lives. | $10.3M / Series A / Jun 16, 2022 | |
| See all 23 investments → | |||
Co-Investors
About Columbia University's Mailman School of Public Health
Columbia University's Mailman School of Public Health is the Mailman School has been at the forefront of public health research, education, and community collaboration. Addressing everything from chronic disease to HIV/AIDS to healthcare policy, the School tackles today’s pressing public health issues, translating research into action.
Columbia University's Mailman School of Public Health Contacts
| Name | Phone | Socials | |
|---|---|---|---|
John Rowe
Professor in the Department of Health Policy & Management
|
|||
|
Chelsea Clinton
Adjunct Assistant Professor
|
|||
Cyrus Massoumi
Board of Advisors
|
|||
Daniel Barth-Jones
Professor
|
|||
Francoise Simon
Professor Emerita, Columbia University Senior Faculty
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Chelsea Clinton invest in?
Chelsea Clinton invests primarily in Health Care, Medical and Health Diagnostics startups, most often at Seed and Series A stage. Most of the 23 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Chelsea Clinton's check size?
Chelsea Clinton typically joins rounds of $2M–$8.8M at Seed and $10M–$130M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Chelsea Clinton participates in.
When did Chelsea Clinton last invest?
The most recent investment recorded for Chelsea Clinton closed in Feb 2026. Shizune tracks 23 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
